Key Account Manager

Cpl; München; Hybrid; EUR 95.000 - 112.000; Vollzeit

Zusammenfassung

Cpl in Germany is recruiting two Key Account Managers to support the launch of an innovative haemoglobinopathy gene therapy. The roles are field-based across North Germany with territories Hamburg-Bremen-Hannover and Berlin-Leipzig-Dresden, with home working and occasional travel to the Munich office.

Haematology experience is preferred, or strong experience in rare disease, complex therapies, or hospital-based specialty care.

Qualifikationen

• Field-based KAM role targeting haemato/rare disease or complex therapies.
• 12-month temporary contract with potential for extension.
• Managing strategic accounts and relationships with HCPs.

Aufgaben

• Lead account identification, prioritisation and strategic account planning.
• Map customer and patient populations and build relationships with HCPs.
• Support awareness, adoption and successful implementation of the therapy.

Kenntnisse

Haematology experience

Rare disease experience

Hospital-based specialty care

Jobbeschreibung

Key Account Manager, Germany (Various locations)

We are supporting a leading global biopharmaceutical company with the appointment of two Key Account Managers to support the launch of an innovative haemoglobinopathy gene therapy in Germany. These are exciting, field-based opportunities for experienced KAMs with a background in haematology, rare disease or complex therapies, offering the chance to play a key role in a high-profile launch.

Overview:

• Key Account Manager positions covering North Germany
• €8,500-€10,000 gross monthly salary + €24,000 annual commission opportunity
• Territories: Hamburg-Bremen-Hannover and Berlin-Leipzig-Dresden
• 12-month temporary contract
• Field-based role, with home working and occasional travel to the Munich office
• Lead account identification, prioritisation and strategic account planning
• Map customer and patient populations and build strong relationships with HCPs
• Support awareness, adoption and successful implementation of the therapy
• Haematology experience preferred, or strong experience in rare disease, complex therapies or hospital-based specialty care